This is a group of inherited conditions where your body doesn't properly break down the amino acid lysine. This leads to high levels of lysine in your blood. It can cause various symptoms, including developmental delays, problems with muscle tone, and digestive issues. It's usually passed down through families.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Hyperlysinemia is a very rare inherited condition in which the body cannot break down lysine normally, so lysine builds up in the blood. Lysine is one of the amino acids that make up protein, and everyone takes it in through food. The body does not store extra amino acids, so it usually breaks down what it does not need. In hyperlysinemia, the first steps of that breakdown, which happen mainly in the liver, do not work properly. There are two types. In type I, the more common one, lysine is raised in the blood. In type II, also called saccharopinuria, lysine is raised and a related substance called saccharopine also appears in the urine. What the condition means for a person's health is less clear than the name suggests. Some people with hyperlysinemia have had developmental delay, intellectual disability, seizures, muscle stiffness or behavior problems. But many others, possibly as many as half, have no symptoms at all and only find out through a blood or urine test. Specialists now generally regard type I as a harmless biochemical difference rather than a disease, while acknowledging that this cannot be stated with complete certainty. Type II has been studied in fewer people and is less well understood.
Hyperlysinemia is caused by changes (variants) in a gene called AASS, which carries the instructions for the enzyme that starts lysine breakdown. It is inherited in an autosomal recessive pattern: a person has the condition only when both copies of the gene are affected, one from each parent. Parents who each carry one changed copy usually have no symptoms, and when both parents are carriers, each child has a one in four chance of inheriting the condition. Nothing a person eats or does causes hyperlysinemia, and there are no known triggers that make it worse. The early link between hyperlysinemia and intellectual disability came mostly from testing children who were already being evaluated for neurological or developmental problems. That kind of testing finds high lysine more often in people who have symptoms for other reasons. When researchers looked instead at people found through newborn screening or family testing, they could not attribute any health problems to the high lysine itself. In some people with both hyperlysinemia and serious neurological problems, another cause has turned up, such as a larger genetic deletion that also removes a neighboring gene important for the brain.
Hyperlysinemia is usually found on a blood test called a plasma amino acid analysis, which measures the levels of individual amino acids. In hyperlysinemia caused by AASS variants, lysine is typically above 600 micromoles per liter and can reach about 2,000, compared with a usual adult range of roughly 110 to 250. A urine test can show whether saccharopine is present, which points to type II. Occasionally the condition is picked up through newborn urine screening, which only some screening programs perform. A smaller rise in lysine, below about 600, more often reflects a different metabolic disorder, such as a urea cycle disorder or an organic acid disorder, and those conditions need their own evaluation. A rare and serious disorder called 2,4-dienoyl-CoA reductase (DECR) deficiency can also raise lysine, alongside poor growth, developmental delay and vision problems. Genetic testing of the AASS gene confirms the diagnosis and helps tell the types apart. When someone with hyperlysinemia also has developmental or neurological problems, a metabolic or genetics specialist usually looks carefully for another explanation rather than assuming the lysine level is responsible.
Hyperlysinemia has no proven treatment, and for most people, including infants found through screening, no treatment is needed. A low-protein or lysine-restricted diet has been tried in some people with symptoms, but it has not been shown to help. Lysine is an essential nutrient that the body cannot make, so any dietary change should be decided with a metabolic specialist and dietitian rather than started independently. Care focuses instead on the person's actual needs. When a child has developmental delay, seizures or other neurological problems, these are treated in the usual way, for example with speech, physical or occupational therapy, educational support and seizure medicine, whatever the underlying cause turns out to be.
For people with type I who have no symptoms, the outlook appears to be ordinary health. A boy found through newborn screening was developing normally without treatment, and a woman with hyperlysinemia has had a healthy child. Because so few people have been followed over many years, specialists still describe the long-term picture as likely, rather than definitely, benign. People who do have symptoms vary widely, from mild learning or behavior difficulties to severe neurological disability, even within the same family. In those cases, the course usually depends more on the underlying cause of the symptoms than on the lysine level. Type II has fewer reported cases, so its outlook is less certain. Follow-up is usually with a metabolic or genetics clinic, often less frequent once a child is developing well. Genetic counseling can help families understand the chance of the condition in future children and whether brothers and sisters might want testing.
Ask for a referral to a metabolic or genetics specialist if a blood or urine test shows high lysine, or if a newborn screening result suggests hyperlysinemia, so the cause and type can be confirmed. For a child with known hyperlysinemia, contact the care team if you notice delays in speech, movement or learning, a loss of skills the child already had, a seizure, or new muscle stiffness or weakness, so these can be evaluated rather than assumed to be part of the condition.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hyperlysinemias is like, what's helped you, or ask the community a question.